Analysis of mutant and total huntingtin expression in Huntington’s disease murine models
Abstract Huntington’s disease (HD) is a monogenetic neurodegenerative disorder that is caused by the expansion of a polyglutamine region within the huntingtin (HTT) protein, but there is still an incomplete understanding of the molecular mechanisms that drive pathology. Expression of the mutant form...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f0f9716e3bb54bde98e7f84e35b5a6f0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f0f9716e3bb54bde98e7f84e35b5a6f0 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f0f9716e3bb54bde98e7f84e35b5a6f02021-12-02T13:34:00ZAnalysis of mutant and total huntingtin expression in Huntington’s disease murine models10.1038/s41598-020-78790-52045-2322https://doaj.org/article/f0f9716e3bb54bde98e7f84e35b5a6f02020-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-78790-5https://doaj.org/toc/2045-2322Abstract Huntington’s disease (HD) is a monogenetic neurodegenerative disorder that is caused by the expansion of a polyglutamine region within the huntingtin (HTT) protein, but there is still an incomplete understanding of the molecular mechanisms that drive pathology. Expression of the mutant form of HTT is a key aspect of diseased tissues, and the most promising therapeutic approaches aim to lower expanded HTT levels. Consequently, the investigation of HTT expression in time and in multiple tissues, with assays that accurately quantify expanded and non-expanded HTT, are required to delineate HTT homeostasis and to best design and interpret pharmacodynamic readouts for HTT lowering therapeutics. Here we evaluate mutant polyglutamine-expanded (mHTT) and polyglutamine-independent HTT specific immunoassays for validation in human HD and control fibroblasts and use to elucidate the CSF/brain and peripheral tissue expression of HTT in preclinical HD models.Valentina FodaleRoberta PintauroManuel DaldinRoberta AltobelliMaria Carolina SpieziaMonica BisbocciDouglas MacdonaldAlberto BrescianiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-13 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Valentina Fodale Roberta Pintauro Manuel Daldin Roberta Altobelli Maria Carolina Spiezia Monica Bisbocci Douglas Macdonald Alberto Bresciani Analysis of mutant and total huntingtin expression in Huntington’s disease murine models |
description |
Abstract Huntington’s disease (HD) is a monogenetic neurodegenerative disorder that is caused by the expansion of a polyglutamine region within the huntingtin (HTT) protein, but there is still an incomplete understanding of the molecular mechanisms that drive pathology. Expression of the mutant form of HTT is a key aspect of diseased tissues, and the most promising therapeutic approaches aim to lower expanded HTT levels. Consequently, the investigation of HTT expression in time and in multiple tissues, with assays that accurately quantify expanded and non-expanded HTT, are required to delineate HTT homeostasis and to best design and interpret pharmacodynamic readouts for HTT lowering therapeutics. Here we evaluate mutant polyglutamine-expanded (mHTT) and polyglutamine-independent HTT specific immunoassays for validation in human HD and control fibroblasts and use to elucidate the CSF/brain and peripheral tissue expression of HTT in preclinical HD models. |
format |
article |
author |
Valentina Fodale Roberta Pintauro Manuel Daldin Roberta Altobelli Maria Carolina Spiezia Monica Bisbocci Douglas Macdonald Alberto Bresciani |
author_facet |
Valentina Fodale Roberta Pintauro Manuel Daldin Roberta Altobelli Maria Carolina Spiezia Monica Bisbocci Douglas Macdonald Alberto Bresciani |
author_sort |
Valentina Fodale |
title |
Analysis of mutant and total huntingtin expression in Huntington’s disease murine models |
title_short |
Analysis of mutant and total huntingtin expression in Huntington’s disease murine models |
title_full |
Analysis of mutant and total huntingtin expression in Huntington’s disease murine models |
title_fullStr |
Analysis of mutant and total huntingtin expression in Huntington’s disease murine models |
title_full_unstemmed |
Analysis of mutant and total huntingtin expression in Huntington’s disease murine models |
title_sort |
analysis of mutant and total huntingtin expression in huntington’s disease murine models |
publisher |
Nature Portfolio |
publishDate |
2020 |
url |
https://doaj.org/article/f0f9716e3bb54bde98e7f84e35b5a6f0 |
work_keys_str_mv |
AT valentinafodale analysisofmutantandtotalhuntingtinexpressioninhuntingtonsdiseasemurinemodels AT robertapintauro analysisofmutantandtotalhuntingtinexpressioninhuntingtonsdiseasemurinemodels AT manueldaldin analysisofmutantandtotalhuntingtinexpressioninhuntingtonsdiseasemurinemodels AT robertaaltobelli analysisofmutantandtotalhuntingtinexpressioninhuntingtonsdiseasemurinemodels AT mariacarolinaspiezia analysisofmutantandtotalhuntingtinexpressioninhuntingtonsdiseasemurinemodels AT monicabisbocci analysisofmutantandtotalhuntingtinexpressioninhuntingtonsdiseasemurinemodels AT douglasmacdonald analysisofmutantandtotalhuntingtinexpressioninhuntingtonsdiseasemurinemodels AT albertobresciani analysisofmutantandtotalhuntingtinexpressioninhuntingtonsdiseasemurinemodels |
_version_ |
1718392831793430528 |